Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Habb-e-Kabid-Naushadri is a traditional Unani herbal-mineral formulation manufactured by Dawakhana Tibbiya (Dawakhana Tibbiya College, AMU) and other traditional medicine manufacturers like Hamdard. It is primarily indicated for liver ailments, such as hepatitis, hepatomegaly (enlargement of the liver), and cirrhosis, as well as digestive issues including indigestion, flatulence, loss of appetite, and constipation. The formulation contains natural ingredients such as Naushadar (Ammonium Chloride), Namak Siyah (Black Salt), Namak Sang (Rock Salt), Suhaga Biryan (Borax), Halela Siyah (Terminalia chebula), and Zanjabeel (Ginger), which work synergistically to support liver function, promote detoxification, stimulate appetite, and act as a mild laxative.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Habb-e-Kabid-Naushadri.